OG

Ojai Goliad

North America, Texas, United States, Dallas

Description

Ojai Goliad, LLC is a venture capital firm that focuses on biotech investments and co-development opportunities in life science companies.

Investor Profile

Ojai Goliad has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series D (33%)
  • Series C (33%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ojai Goliad frequently co-invest with?

Startech Early Ventures
North America, Texas, United States, Richardson
Co-Investments: 2
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
The University of Texas at Austin
North America, Texas, United States, Austin
Co-Investments: 1
CI
North America, Texas, United States, Dallas
Co-Investments: 2

What are some of recent deals done by Ojai Goliad?

Reata Pharmaceuticals

Irving, Texas, United States

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

BiopharmaBiotechnologyPharmaceutical
Series DJun 26, 2006
Amount Raised: $7,050,000
Reata Pharmaceuticals

Irving, Texas, United States

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

BiopharmaBiotechnologyPharmaceutical
Series CNov 12, 2004
Amount Raised: $12,000,000
Reata Pharmaceuticals

Irving, Texas, United States

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

BiopharmaBiotechnologyPharmaceutical
Series BSep 12, 2003
Amount Raised: $3,600,000